Evidence map›Paper›PMID 33658331›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2021

Impacts of introducing and lifting nonpharmaceutical interventions on COVID-19 daily growth rate and compliance in the United States.

Surya Singh, Mujaheed Shaikh, Katharina Hauck, Marisa Miraldo

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. "Frontiers in pediatrics · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Association of vaccination, international travel, public health and social measures with lineage dynamics of SARS-CoV-2.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Surya SinghHealth Economics Research Center, Nuffield Department of Population Health, University of Oxford, Oxford OX3 7LF, United Kingdom.ORCID https://orcid.org/0000-0002-3005-8073
Mujaheed ShaikhPolitical Economy Cluster, Hertie School, 10117 Berlin, Germany.
Katharina HauckDepartment of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London W2 1PG, United Kingdom.ORCID https://orcid.org/0000-0003-3138-4169
Marisa MiraldoDepartment of Economics and Public Policy, Business School, Imperial College London, London SW7 2AZ, United Kingdom; m.miraldo@imperial.ac.uk.

Funding

Medical Research Council MC_PC_19012Medical Research Council MR/R015600/1
6 · The paper itself

Abstract

We evaluate the impacts of implementing and lifting nonpharmaceutical interventions (NPIs) in US counties on the daily growth rate of COVID-19 cases and compliance, measured through the percentage of devices staying home, and evaluate whether introducing and lifting NPIs protecting selective populations is an effective strategy. We use difference-in-differences methods, leveraging on daily county-level data and exploit the staggered introduction and lifting of policies across counties over time. We also assess heterogenous impacts due to counties' population characteristics, namely ethnicity and household income. Results show that introducing NPIs led to a reduction in cases through the percentage of devices staying home. When counties lifted NPIs, they benefited from reduced mobility outside of the home during the lockdown, but only for a short period. In the long term, counties experienced diminished health and mobility gains accrued from previously implemented policies. Notably, we find heterogenous impacts due to population characteristics implying that measures can mitigate the disproportionate burden of COVID-19 on marginalized populations and find that selectively targeting populations may not be effective.

Indexed as

Communicable Disease ControlCOVID-19Guideline AdherenceHealth PolicyHumansPandemicsPhysical DistancingSARS-CoV-2Socioeconomic FactorsUnited StatescomplianceCOVID-19lockdown measuresnonpharmaceutical interventionspublic policy

Identifiers

PMID33658331
PMCPMC8000285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.